Search results for "Catheter"

showing 10 items of 482 documents

Less invasive (common) femoral artery aneurysm repair using endografts and limited dissection

2013

Objective We report our experience with the treatment of femoral artery aneurysms (FAAs) under local anaesthesia with limited dissection, using endografts to facilitate the proximal anastomosis and some distal anastomoses. Method Between January 2006 and December 2010, six males, mean age 72 years (range, 65–80 years) with FAAs were treated at the University Hospital of Zurich. All operations were performed under local anaesthesia with analgosedation, except for one performed under spinal anaesthesia. After limited dissection and puncture of the anterior wall of the FAA, a sheath and a self-expanding endograft were introduced over a guide wire and with fluoroscopy they were guided intralumi…

Malemedicine.medical_specialtyAnastomosismedicine.medical_treatmentEndograft610 Medicine & healthFemoral arteryDissection (medical)AnastomosisSettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineAneurysmmedicine.arteryDeep Femoral ArteryHumansMedicineAgedMedicine(all)Aged 80 and over10042 Clinic for Diagnostic and Interventional Radiologybusiness.industryEndovascular ProceduresBalloon catheterExternal iliac arteryStentmedicine.diseaseAneurysmBlood Vessel Prosthesis10020 Clinic for Cardiac Surgery2746 SurgerySurgeryFemoral ArteryCommon femoral arteryFemaleSurgeryRadiologyCardiology and Cardiovascular MedicinebusinessCommon femoral artery Aneurysm Endograft Anastomosis
researchProduct

Continuous monitoring of mixed venous oxygen saturation in infants after cardiac surgery

1989

Continuous mixed venous oxygen saturation (SvO2c) was measured in 16 infants immediately after cardiac surgery. A polyurethane 4F, dual channel catheter (Opticath, Modell U440, Oximetrix) with fiberoptic filaments was introduced into the pulmonary artery during cardiothoracic surgery. The catheters were left in place for an average of 67.5 h (range 27 h -125 h) and there were no catheter-related complications. Correlation between continuous in vivo SvO2 values and in vitro values was satisfactory (r = 0.85), whereas a correlation between SvO2c and arterial oxygen saturation (SaO2) was not found (r = 0.07). The sampled arterial lactate values were inversely correlated to the simultaneously m…

Malemedicine.medical_specialtyApparent oxygen utilisationchemistry.chemical_elementCritical Care and Intensive Care MedicineOxygenOxygen ConsumptionIntensive caremedicine.arteryHumansMedicinePostoperative PeriodCardiac Surgical ProceduresMonitoring Physiologicbusiness.industryContinuous monitoringInfantCardiac surgeryCatheterchemistryCardiothoracic surgeryAnesthesiaPulmonary arteryLactatesFemaleBlood Gas AnalysisbusinessIntensive Care Medicine
researchProduct

Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound

2007

Radiofrequency ablation (RFA) is increasingly being used as percutaneous treatment of choice for patients with early stage hepatocellular carcinoma (HCC). An accurate assessment of the RFA therapeutic response is of crucial importance, considering that a complete tumor ablation significantly increases patient survival, whereas residual unablated tumor calls for additional treatment. Imaging modalities play a pivotal role in accomplishing this task, but ultrasound (US) is not considered a reliable modality for the evaluation of the real extent of necrosis, even when color/power Doppler techniques are used. Recently, newer microbubble-based US contrast agents used in combination with grey-sca…

Malemedicine.medical_specialtyCarcinoma HepatocellularPercutaneousRadiofrequency ablationUrologymedicine.medical_treatmentSulfur HexafluorideContrast MediaCatheter ablationSensitivity and Specificitylaw.inventionImaging Three-DimensionallawHumansMedicineRadiology Nuclear Medicine and imagingStage (cooking)PhospholipidsUltrasonography InterventionalAgedAged 80 and overRadiological and Ultrasound Technologybusiness.industryLiver NeoplasmsUltrasoundGastroenterologyGeneral MedicineRadiofrequency ablationcontrast-enhanced ultrasound hepatocellular carcinomamedicine.diseaseTreatment OutcomeHepatocellular carcinomaCatheter AblationDisease ProgressionMicrobubblesFemaleRadiologybusinessContrast-enhanced ultrasoundAbdominal Imaging
researchProduct

Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Before Liver Transplantation: A Prospective Study with Histopathologic Comparison

2006

OBJECTIVE. The aims of this study were to determine the feasibility and efficacy of percutaneous radiofrequency ablation in patients with hepatocellular carcinoma waiting for liver transplantation and to compare the radiologic and pathologic findings. SUBJECTS AND METHODS. Twenty-six patients with 35 hepatocellular carcinomas were addressed for transplantation. Complications of the procedures were recorded. Primary and secondary technique effectiveness and causes of exclusion from the waiting list were assessed. After transplantation, tumor recurrence was evaluated for at least 1 year in all patients. Radiologic-pathologic comparison of the explant was performed. RESULTS. Percutaneous radio…

Malemedicine.medical_specialtyCarcinoma HepatocellularPercutaneousRadiofrequency ablationmedicine.medical_treatmentLiver transplantationlaw.inventionlawPreoperative CaremedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studyablation cancer hepatocellular carcinoma liver transplantation radiofrequencybusiness.industryLiver NeoplasmsCancerGeneral MedicineMiddle Agedmedicine.diseaseAblationLiver TransplantationSurgeryRadiographyTransplantationHepatocellular carcinomaCatheter AblationFeasibility StudiesFemaleRadiologybusinessFollow-Up StudiesAmerican Journal of Roentgenology
researchProduct

Incidence of new foci of hepatocellular carcinoma after radiofrequency ablation: role of multidetector CT

2012

Purpose. The authors sought to assess the incidence of new foci of hepatocellular carcinoma (HCC) using multidetector computed tomography (MDCT) in patients treated with radiofrequency ablation (RFA). Materials and methods. Two readers retrospectively reviewed by consensus the follow-up MDCT studies of 125 patients (88 men and 37 women; mean age 68 years) with 141 HCCs (size 1–5.2 cm; mean 2.2 cm) treated with RFA. MDCT follow-up was performed at 1 and 3 months and every 6–12 months thereafter. Reviewers assessed: (1) the presence of new HCC foci in the same liver segment or in a different segment; (2) complete or incomplete tumor ablation; (3) tumour progression. Results. A total of 113 ne…

Malemedicine.medical_specialtyCarcinoma HepatocellularRadiofrequency ablationMultidetector ctSettore MED/01 - Statistica Medicalaw.inventionLiver neoplasmslawMultidetector Computed TomographymedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesNeuroradiologyChi-Square Distributionmedicine.diagnostic_testbusiness.industryIncidenceIncidence (epidemiology)Radiofrequency ablation (RFA)UltrasoundInterventional radiologyGeneral MedicineMiddle AgedHCCSmedicine.diseasedigestive system diseasesTreatment OutcomeLiverHepatocellular carcinomaCatheter AblationDisease ProgressionRadiofrequency ablation (RFA); Liver; CT; Liver neoplasmsFemaleRadiologyNeoplasm Recurrence LocalSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessFollow-Up StudiesCTLa radiologia medica
researchProduct

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.

2020

Background: Percutaneous left atrial appendage closure (LAAC) exposes to the risk of device thrombosis in patients with atrial fibrillation who frequently have a contraindication to full anticoagulation. Thereby, dual antiplatelet therapy (DAPT) is usually preferred. No randomized study has evaluated nonvitamin K antagonist oral anticoagulant after LAAC, and we decided to evaluate the efficacy and safety of reduced doses of rivaroxaban after LAAC. Methods: ADRIFT (Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure) is a multicenter, phase IIb study, which randomized 105 patients after successful LAAC to eith…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsAntithrombin IIIAtrial AppendagePilot Projects030204 cardiovascular system & hematologyFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanLeft atrialHeart RateInternal medicineAtrial FibrillationMedicineHumansAtrial Appendage030212 general & internal medicineContraindicationBlood CoagulationAgedAppendageAged 80 and overRivaroxabanbusiness.industryDual Anti-Platelet TherapyAtrial fibrillationThrombosisClopidogrelmedicine.diseasePeptide Fragments3. Good healthTreatment OutcomeCardiologyAtrial Function LeftFemaleProthrombinFranceCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsPeptide HydrolasesCirculation. Cardiovascular interventions
researchProduct

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation

2009

Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the treatment of patients with atrial fibrillation (AF) and with a high risk of stroke who are not eligible for long-term anticoagulation therapy. The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure. Methods: From July 2004 to June 2007, 20 patients (13 male, mean age 69 ± 8 years) with non–valvular AF (NV-AF) underwent LAA percutaneous closure using the PLAATO™ system, implanted through a transeptal access. All patients had contraindications to anticoagulant therapy and were at high risk for cardioembolic stroke (mean CHADS2 score 3 ± 1.2). A trans…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsThromboembolism.left atrial appendage occlusionmedicine.medical_treatmentEmbolismSettore MED/11 - Malattie dell'Apparato CardiovascolareTransesophagealLeft atrial appendage occlusionPericardial effusionRisk AssessmentLeft atrialInternal medicineAtrial FibrillationmedicineHumansRadiology Nuclear Medicine and imagingAtrial Appendageatrial fibrillation; left atrial appendage occlusion; thromboembolism; Aged; Atrial Fibrillation; Contraindications; Echocardiography Transesophageal; Embolism; Equipment Design; Feasibility Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Anticoagulants; Atrial Appendage; Cardiac Catheterization; Chronic DiseaseStrokeAgedbusiness.industryContraindicationsAnticoagulantsAtrial fibrillationGeneral MedicineEquipment DesignthromboembolismMiddle Agedmedicine.diseaseSurgeryStrokeTreatment OutcomePericardiocentesisEchocardiographyChronic DiseaseCardiologyPatent foramen ovaleFeasibility StudiesFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealPlatelet Aggregation Inhibitors
researchProduct

Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation

2013

ObjectivesThis study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE]).BackgroundRisk stratification after TAVI remains challenging. The use of biomarkers in this setting represents an unmet need.MethodsCA125 was measured in 228 patients before and after TAVI. The association with outcomes was assessed using parametric Cox regression and joint modeling for baseline and longitudinal analyses, respectively. CA125 was evaluated as logarithm transforma…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsAortic Valve InsufficiencyMyocardial InfarctionKaplan-Meier EstimateRisk AssessmentCA125Interquartile rangeRisk FactorsInternal medicineMedicineHumansMyocardial infarctionLongitudinal StudiesRegistriesStroketranscatheter aortic valve implantationTumor markerAgedProportional Hazards ModelsAged 80 and overHeart FailureHeart Valve Prosthesis ImplantationProportional hazards modelbusiness.industryMembrane ProteinsAortic Valve Stenosismedicine.diseasejoint modelingHospitalizationStrokeLogistic ModelsTreatment OutcomeCardiovascular DiseasesHeart failureCA-125 AntigenMultivariate AnalysisCardiologybiomarkerBiomarker (medicine)FemaleprognosisbusinessCardiology and Cardiovascular MedicineMaceBiomarkersJACC: Cardiovascular Interventions
researchProduct

Long-term beneficial effects of PTCA on segmental early relaxation in disease of the left anterior descending coronary artery.

1988

The relationship between regional left ventricular (LV) motion and global pressure relaxation of the left ventricle remains unclear. To clarify the recent concept of segmental early relaxation in coro nary artery disease, the authors in vestigated two groups of patients. In group I, all 12 patients (mean age 47±7 years) exhibited evidence of a normal heart after an extensive in vestigation. In group II, 25 patients (55±7 years) presented an isolated stenosis of the left anterior descend ing coronary artery, and they under went a hemodynamic investigation before and after (six to nine months) a durable successful percutaneous transluminal coronary angioplasty (PTCA). After all conventional …

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsHeart VentriclesHemodynamicsCoronary Disease030204 cardiovascular system & hematologyAnterior Descending Coronary Artery03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineBeneficial effectsRelaxation (psychology)business.industryHemodynamicsMiddle Agedmedicine.diseaseMyocardial ContractionSurgeryStenosismedicine.anatomical_structureVentricleCoronary vesselCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAngioplasty BalloonArteryFollow-Up StudiesAngiology
researchProduct

Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.

2020

This study was designed to assess hemodynamic changes in response to transcatheter tricuspid valve edge-to-edge repair (TTVR) and to identify hemodynamic predictors associated with mortality.Severe tricuspid regurgitation (TR) is associated with high mortality. TTVR effectively alleviates heart failure symptoms, but comprehensive hemodynamic characterization of patients undergoing TTVR is currently lacking.This international, multicenter study included 236 patients undergoing TTVR. Data from clinical assessment, echocardiography, intraprocedural right heart catheterization, and noninvasive cardiac output measurement were analyzed. Hemodynamic predictors for mortality were identified using l…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsHemodynamicsRegurgitation (circulation)030204 cardiovascular system & hematologyNew york heart association03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineTRICUSPID VALVE REPAIRAgedHeart FailureHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryProportional hazards modelHemodynamicsRecovery of Functionmedicine.diseaseTricuspid Valve Insufficiencymedicine.anatomical_structureTreatment OutcomeMulticenter studyHeart failureCardiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessJACC. Cardiovascular interventions
researchProduct